ALTERNATIVE FINANCING FORMS
FOR ENTREPRENEURS AND INVESTORS
News
Photo: Markus Wildmoser, Managing Director at MP Corporate Finance (Photo © MP)

ACH Solution sold to BC Partners subsidiary IGS GeboJagema

Photo: Markus Wild­mo­ser, Mana­ging Direc­tor at MP Corpo­rate Finance (Photo © MP)
22. Janu­ary 2026

Frank­furt / Vienna / Fischl­ham (AT) / Eind­ho­ven (NL) — MP Corpo­rate Finance, a leading inter­na­tio­nal M&A advi­sory firm specia­li­zing in the Euro­pean indus­trial sector, has exclu­si­vely advi­sed the share­hol­ders of ACH Solu­tion GmbH (“ACH”) on the sale to IGS Gebo­Ja­gema (“IGS”), a port­fo­lio company of BC Part­ners. With the acqui­si­tion, IGS streng­thens its exper­tise in sili­cone injec­tion molding and expands its service port­fo­lio for deman­ding appli­ca­ti­ons in medi­cal tech­no­logy. The tran­sac­tion is expec­ted to close in the first quar­ter of 2026, subject to regu­la­tory appr­ovals. For MP Corpo­rate Finance, this tran­sac­tion marks the 42nd successfully advi­sed deal in the engi­nee­red mate­ri­als sector. 

Leading tool­ma­ker for sili­cone injec­tion molding in the medi­cal sector

ACH Solu­tion GmbH, head­quar­te­red in Fischl­ham, Upper Austria, with an addi­tio­nal site in Sara­sota, Florida, employs around 90 people and is one of the leading tool­ma­kers in the field of sili­cone injec­tion molding. The company deve­lops and manu­fac­tures high-precis­­ion molds for LSR and HTV proces­ses and also offers supple­men­tary services along the entire sili­cone mold manu­fac­tu­ring value chain. ACH’s products are used in parti­cu­lar by inter­na­tio­nal medi­cal tech­no­logy compa­nies that place the highest demands on quality, repro­du­ci­bi­lity and process reliability. 

Stra­te­gic expan­sion of the medi­cal tech­no­logy port­fo­lio at IGS GeboJagema

Since its foun­da­tion in 1945, IGS Gebo­Ja­gema has deve­lo­ped into a leading inter­na­tio­nal manu­fac­tu­rer of injec­tion molds for ther­mo­pla­s­tic appli­ca­ti­ons in medi­cal tech­no­logy. Head­quar­te­red in Eind­ho­ven, the Nether­lands, IGS serves renow­ned custo­mers world­wide, parti­cu­larly in the health­care sector. Since August 2025, IGS has also streng­the­ned the port­fo­lio of BC Part­ners, an inter­na­tio­nally active invest­ment firm with a focus on private equity, credit and real estate in Europe and North America. The acqui­si­tion of ACH is part of the joint buy-and-build stra­tegy of IGS and BC Part­ners in highly specia­li­zed indus­trial niche markets and marks a further step in buil­ding a leading global tooling group for medi­cal appli­ca­ti­ons. The part­ner­ship of two market leaders in injec­tion mold making will enable complex chal­lenges to be addres­sed and highly tech­ni­cal custo­mer requi­re­ments to be relia­bly met. 

Chris­tian Hefner, share­hol­der of ACH Solu­tion GmbH, comm­ents: “Our philo­so­phy at ACH has always been to push boun­da­ries. And in MP, we have found an expe­ri­en­ced part­ner who has guided us through this unique process. MP’s deep market under­stan­ding and stra­te­gic exper­tise in the tooling sector combi­ned with profes­sio­na­lism, commit­ment and tran­sac­tion expe­ri­ence were excep­tio­nal throug­hout the process.”

Land­mark tran­sac­tion in a stron­gly conso­li­da­ting market

The sales process was charac­te­ri­zed by an inter­na­tio­nal and highly compe­ti­tive bidding field. MP Corpo­rate Finan­ce’s team of experts deve­lo­ped a convin­cing equity story based on their in-depth indus­try know­ledge of injec­tion mold making and the sili­cone indus­try and targe­ted stra­te­gic and finan­cial inves­tors world­wide. “This tran­sac­tion is a mile­stone in global tool­ma­king for medi­cal tech­no­logy. The merger of two tech­no­logy leaders for sili­cone and ther­mo­pla­s­tic molds crea­tes a provi­der that can cover the most deman­ding appli­ca­ti­ons in the medi­cal sector holi­sti­cally,” explains Markus Wild­mo­ser (photo © MP), Mana­ging Direc­tor at MP Corpo­rate Finance.“The strong demand in the MedTech sector and the incre­asing conso­li­da­tion pres­sure in the plas­tics market are curr­ently driving stra­te­gic mergers.” 

MP Corpo­rate Finance confirms track record in the focus sector “Engi­nee­red Mate­ri­als

For MP Corpo­rate Finance, the merger marks the 42nd successfully advi­sed tran­sac­tion in the engi­nee­red mate­ri­als sector. Recent tran­sac­tions in this sector include, for exam­ple, the sale of Lapo Compound to Poly­ram Plas­tic Indus­tries in 2025. 

About MP Corpo­rate Finance

MP Corpo­rate Finance is the leading inter­na­tio­nal M&A consul­tancy specia­li­zing in the indus­trial sector. As an expe­ri­en­ced part­ner, MP supports medium-sized compa­nies and manage­ment teams, private equity decis­­ion-makers as well as entre­pre­neu­rial confi­dants in complex tran­sac­tions on both the sell and buy side and provi­des support in the context of capi­tal procu­re­ment, buy-and-build stra­te­gies, carve-outs or throug­hout the entire private equity life­cy­cle. MP was foun­ded in Vienna in the 1990s by Roman Göd and Gregor Nischer as the first Euro­pean M&A firm with a sector-focu­­sed advi­sory approach. Today, the company employs more than 85 expe­ri­en­ced hands-on experts at five loca­ti­ons world­wide — in Vienna, Frank­furt, London, Istan­bul and Chicago — making it the largest indus­trial M&A team in Europe. With its unique sector focus, MP has successfully advi­sed on more than 700 indus­trial tran­sac­tions invol­ving invest­ment compa­nies, SMEs and corpo­ra­ti­ons. — www.mp-corporatefinance.com

About ACH Solution
https://www.ach-solution.at/en

About IGS GeboJagema

Home­page

About BC Partners

Home­page

Subscribe newsletter

Here you can read about the latest transactions, IPOs, private equity deals and venture capital investments, who has raised a new fund, how Buy & Build activities are going.

Get in touch

Contact us!
fyb [at] fyb.de